As of January 22, 2025, Shattuck Labs (STTK) has a market cap of $53.468 million USD. According to our data, Shattuck Labs is ranked No.8114 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $53.47 M |
-7.44%
|
Dec 31, 2024 | $57.77 M |
-83.03%
|
Dec 29, 2023 | $0.34 B |
210.00%
|
Dec 30, 2022 | $0.11 B |
-72.97%
|
Dec 31, 2021 | $0.41 B |
-83.76%
|
Dec 31, 2020 | $2.50 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Arcus Biosciences
RCUS
|
$1.23 B |
-0.000 M
|
USA
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
Exelixis
EXEL
|
$9.39 B |
0.000 M
|
USA
|
CytomX Therapeutics
CTMX
|
$65.57 M |
0.000 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
Market Cap | = | STTK Stock Price | * | STTK Shares Outstanding |
= | $1.12 | * | 47.74 M | |
= | $53.47 M |